Robert Kirkman

2009 - Oncothyreon

In 2009, Robert Kirkman earned a total compensation of $1.3M as President, Chief Executive Officer and Director at Oncothyreon, a 88% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$131,250
Option Awards$796,412
Salary$375,000
Other$11,586
Total$1,314,248

Kirkman received $796.4K in option awards, accounting for 61% of the total pay in 2009.

Kirkman also received $131.3K in non-equity incentive plan, $375K in salary and $11.6K in other compensation.

Rankings

In 2009, Robert Kirkman's compensation ranked 3,584th out of 9,885 executives tracked by ExecPay. In other words, Kirkman earned more than 63.7% of executives.

ClassificationRankingPercentile
All
3,584
out of 9,885
64th
Division
Services
508
out of 1,466
65th
Major group
Engineering, Accounting, Research, Management, And Related Services
46
out of 167
73rd
Industry group
Research, Development, And Testing Services
17
out of 44
61st
Industry
Commercial Physical and Biological Research
17
out of 41
59th
Source: SEC filing on April 24, 2012.

Kirkman's colleagues

We found five more compensation records of executives who worked with Robert Kirkman at Oncothyreon in 2009.

2009

Gary Christianson

Oncothyreon

Chief Operating Officer

2009

Diana Hausman

Oncothyreon

Vice President, Clinical Development

2009

Shashi Karan

Oncothyreon

Secretary

2009

Scott Peterson

Oncothyreon

Vice President, Research and Development

2009

Christopher Henney

Oncothyreon

Chairman

In-depth

You may also like